Metraipolis › archive › dc_f6173350f2be
Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a… — Europe PMC PMID:41407433
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41407433
- DOI
- 10.1136/rmdopen-2025-006333
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:07:05.391Z
- SHA-256 of the archived text
aa8c509464a2911f63d16bc9bda6645bf48e3d24377eda8e7d0a062aed001379- Stable URL of this page
https://metraipolis.com/documento/dc_f6173350f2be
How to cite
Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a… — Europe PMC PMID:41407433 — Europe PMC (en), https://europepmc.org/article/MED/41407433 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6173350f2be (Metraipolis archive dc_f6173350f2be, sha256 aa8c509464a2911f63d16bc9bda6645bf48e3d24377eda8e7d0a062aed001379)
BibTeX
@misc{dcf6173350f2be,
title = {Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a… — Europe PMC PMID:41407433},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41407433},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6173350f2be; sha256 aa8c509464a2911f63d16bc9bda6645bf48e3d24377eda8e7d0a062aed001379},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41407433. Agents can read the archived copy with the MCP tool read_document.